Wockhardt News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Wockhardt from all sources in a single place.

Wockhardt Ltd.

18 Jul 2026, 06:50PM

1900.70

1.30%

Company Update

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find enclosed the copies of Newspaper Advertisement published today i.e. 18th July, 2026 in respect to the information regarding the 27th Annual General Meeting (''AGM'') of the Company, Completion of dispatch of Notice of AGM and Annual Report for FY 2026, and Information about remote e-voting and e-voting facility at AGM.

pdf

Wockhardt Ltd.

17 Jul 2026, 08:46PM

1900.70

1.30%

Corp. Note

Wockhardt Ltd - 532300 - Business Responsibility and Sustainability Reporting (BRSR)

BSE India

Please find enclosed the Business Responsibility and Sustainability Report and Independent Assurance Statement on BRSR Core parameters issued by SGS India Private Limited for the Financial Year ended 31st March, 2026.

pdf

Wockhardt Ltd.

17 Jul 2026, 08:33PM

1900.70

1.30%

Corp. Note

Wockhardt Ltd - 532300 - Reg. 34 (1) Annual Report.

BSE India

Please find enclosed herewith the Annual Report of the Company for the Financial Year 2025-26.

pdf

Wockhardt Ltd.

17 Jul 2026, 08:22PM

1900.70

1.30%

AGM

Wockhardt Ltd - 532300 - Notice Of 27Th Annual General Meeting And The Annual Report Of …

BSE India

Please find enclosed herewith the Notice of 27th Annual General Meeting of Wockhardt Limited scheduled to be held on Monday, 10th August, 2026, at 3:30 p.m. through Video Conferencing/ Other Audio Visual Means and the Annual Report of the Company for the Financial Year 2025-2026.

pdf

Wockhardt Ltd.

10 Jul 2026

1900.70

1.30%

Company Update

Wockhardt Ltd - 532300 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, please find enclosed the Certificate received from MUFG Intime India Private Limited, Registrar and Share Transfer Agent of the Company for the quarter ended 30th June, 2026.

pdf

Wockhardt Ltd.

06 Jul 2026

1900.70

1.30%

Looking beyond generics: Wockhardt is showing the way in antibiotics

Business Standard

Wockhardt's FDA-approved Zaynich marks a breakthrough in India's pharmaceutical innovation, offering a new weapon against antimicrobial resistance

Wockhardt Ltd. is trading above its 200 day SMA of 1482.6

Wockhardt Ltd.

03 Jul 2026

1900.70

1.30%

Company Update

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 30 read with Schedule III (Part A Para A) of SEBI Listing Regulations, please find enclosed herewith newspaper extracts of public notice relating to 27th AGM of the Company, published in Lokmat (marathi) - Chhatrapati Sambhajinagar edition and Business Standard (english) - All India editions on Friday, 3rd July, 2026

pdf

Wockhardt Ltd.

26 Jun 2026

1900.70

1.30%

Company Update

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find enclosed herewith newspaper advertisement published today i.e. 26th June, 2026, regarding the opening of special window for re-lodgment of the transfer of shares held in physical form.

pdf

Wockhardt Ltd.

25 Jun 2026

1900.70

1.30%

SAST

Wockhardt Ltd - 532300 - Closure of Trading Window

BSE India

This is to inform that pursuant to Company''s ''Code of Conduct for regulating, monitoring and reporting of trading by designated persons'' (''the Code''), the Trading Window for dealing in the equity shares of the Company will be closed from 1st July, 2026 untill 48 hours after the declaration of unaudited financial results of the Company for the quarter ended 30th June, 2026.

pdf

Wockhardt Ltd.

12 Jun 2026

1900.70

1.30%

Turnaround? Or execution still under scrutiny

Not Rated: Wockhardt Ltd.

Deven Choksey

Wockhardt has transformed into an innovation-led pharmaceutical company with a strong pipeline of novel antibiotics, highlighted by the USFDA approval of Zaynich.

Wockhardt has gained 36.22% in the last 3 Months

Is Wockhardt Ltd. worth buying?

464 Votes:

Buy 73.49%

Sell 17.03%

Hold 9.48%

RESEARCH REPORTS

Not Rated SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf